发明申请
- 专利标题： ORAL CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS OF BLONANSERIN
- 专利标题（中）： 口服对照释放药物组合物
-
申请号： US13816342申请日： 2011-08-10
-
公开(公告)号： US20130143897A1公开(公告)日： 2013-06-06
- 发明人: Pravin Meghrajji Bhutada , Ashish Ashokrao Deshmukh , Sajeev Chandran , Shirishkumar Kulkarni
- 申请人： Pravin Meghrajji Bhutada , Ashish Ashokrao Deshmukh , Sajeev Chandran , Shirishkumar Kulkarni
- 申请人地址： IN Mumbai, State of Maharashtra
- 专利权人： LUPIN LIMITED
- 当前专利权人： LUPIN LIMITED
- 当前专利权人地址： IN Mumbai, State of Maharashtra
- 优先权： IN891/KOL/2010 20100810
- 国际申请： PCT/IB2011/001843 WO 20110810
- 主分类号： A61K31/496
- IPC分类号： A61K31/496
摘要：
An oral controlled release pharmaceutical composition comprising Blonanserin and release controlling agent(s) and optionally pharmaceutically acceptable excipients is provided. The present invention further relates to a controlled release pharmaceutical composition comprising Blonanserin and release controlling agent(s) such that the composition releases not less than about 80% of Blonanserin within 20 hours, when dissolution is carried out in 900 ml, 0.1 N HCl, USP apparatus Type II (Paddle) at 50 rpm for 20 hrs. The controlled release pharmaceutical composition of the invention releases 50% of Blonanserin between about 4 to 14 hours, when dissolution is carried out in 900 ml, 0.1 N HCl, USP apparatus Type II (Paddle) at 50 rpm.
信息查询
IPC分类:
